✦ LIBER ✦

Advances in anti-VEGF and anti-EGFR therapy for advanced non-small cell lung cancer

✍ Scribed by Reck, Martin; Crinò, Lucio

Book ID: 119319959
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 190 KB
Volume: 63
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2008.05.015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EGFR inhibitors with concurrent thoracic

EGFR inhibitors with concurrent thoracic radiation therapy for locally advanced non-small cell lung cancer

✍ Xu, Yaping; Zhang, Yiping; Ma, Shenglin 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 233 KB

Adjuvant therapy for locally advanced no

Adjuvant therapy for locally advanced non-small cell lung cancer

✍ Keller, Steven M 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Second-line therapy for advanced non-sma

Second-line therapy for advanced non-small-cell lung cancer

✍ Christine L. Hann; Julie R. Brahmer 📂 Article 📅 2006 🏛 Current Science Inc. 🌐 English ⚖ 90 KB

5P EGFR GENE MUTATION IN ADVANCED NON-SM

5P EGFR GENE MUTATION IN ADVANCED NON-SMALL CELL LUNG CANCER

✍ Mehmood, T.; Rashid, A.; Usman, S.; Irfan, M.; Haider, I.; Rehman, K. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Recent advances in etoposide therapy for

Recent advances in etoposide therapy for non-small cell lung cancer

✍ Philip Bonomi 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 504 KB

Non-small cell lung cancer (NSCLC) continues to be a major health problem in the US. In 1990, approximately 120,000 new cases will be diagnosed, and the majority of these patients will have either unresectable disease or resected disease that has a relatively low chance of being cured. A variety of

Recent advances in etoposide therapy for

Recent advances in etoposide therapy for non-small cell lung cancer

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 164 KB